Search For "covid 19 patients in india"
Updated : 10 months, 3 weeks ago IST
New Delhi [India], November 2 (ANI): The top drug regulator has refused Dr Reddy's Laboratories' application, for full marketing authorization of anti-viral drug Remdesivir, for treatment of COVID-19 patients in India.
Updated : 1 year, 1 month ago IST
New Delhi [India], Aug 4 (ANI): The number of recovered COVID-19 patients in India is increasing daily and is now over double the number of active cases, Health Ministry said on Tuesday.
Updated : 1 year, 2 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
New Delhi [India], July 10 (ANI): Union Health Minister Harsh Vardhan on Friday said the recovery rate of COVID-19 patients in India currently stands at about 63 per cent and asserted that India has not reached the community transmission stage, despite being a large country.
Updated : 1 year, 3 months ago IST
New Delhi [India], June 10 (ANI): For the first time, the number of recovered COVID-19 patients on Wednesday surpassed the total active cases in the country, according to the Ministry of Health and Family Welfare.
Updated : 1 year, 4 months ago IST
New Delhi [India], May 28 (ANI): The Health Ministry said on Thursday that the recovery rate of COVID-19 patients in India has gone up to 42.75 per cent after 3,266 patients were cured in the last 24 hours.
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.
Updated : 1 year, 5 months ago IST
Jhajjar (Haryana) [India], April 5 (ANI): The most effective remedy against coronavirus is social distancing, said Union Health and Family Welfare Minister Dr Harsh Vardhan on Sunday.